Loading…
Thor Medical signed a strategic master supply agreement with ARTBIO for a 5-year supply of Thorium-228, with potential revenues of up to NOK 400 million (USD 38 million). The Thorium-228 will be produced at Thor Medical's planned commercial facility at Herøya Industrial Park in Norway, with an investment decision expected in Q1 2025.